Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amag Pharmaceuticals, Inc. (AVM) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amag Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 792977.
Total stock buying since 2015: $9,032,924.
Total stock sales since 2015: $130,188,818.
Total stock option exercises since 2015: $1,360,848.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2020 | 180,466 | $1,173,453 | 4,402,466 | $59,662,946 | 0 | $0 |
2019 | 1,208,016 | $7,758,695 | 1,425 | $19,964 | 0 | $0 |
2018 | 0 | $0 | 25,770 | $641,016 | 0 | $0 |
2017 | 0 | $0 | 8,079 | $165,931 | 0 | $0 |
2016 | 0 | $0 | 4,938 | $122,462 | 0 | $0 |
2015 | 3,230 | $100,776 | 1,415,359 | $69,576,499 | 101,234 | $1,360,848 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2020-10 | 0 | $0 | 4,390,000 | $59,585,470 | 0 | $0 |
2020-03 | 24,000 | $116,880 | 0 | $0 | 0 | $0 |
2020-02 | 36,000 | $298,439 | 0 | $0 | 0 | $0 |
2020-01 | 120,466 | $758,134 | 12,466 | $77,476 | 0 | $0 |
2019-08 | 685,000 | $4,480,370 | 0 | $0 | 0 | $0 |
2019-06 | 498,016 | $3,017,575 | 0 | $0 | 0 | $0 |
2019-05 | 25,000 | $260,750 | 0 | $0 | 0 | $0 |
2019-03 | 0 | $0 | 1,425 | $19,964 | 0 | $0 |
2018-08 | 0 | $0 | 5,000 | $125,000 | 0 | $0 |
2018-06 | 0 | $0 | 20,000 | $500,000 | 0 | $0 |
2018-03 | 0 | $0 | 770 | $16,016 | 0 | $0 |
2017-08 | 0 | $0 | 1,250 | $20,937 | 0 | $0 |
2017-07 | 0 | $0 | 4,938 | $98,760 | 0 | $0 |
2017-05 | 0 | $0 | 1,891 | $46,234 | 0 | $0 |
2016-10 | 0 | $0 | 4,938 | $122,462 | 0 | $0 |
2015-11 | 3,230 | $100,776 | 0 | $0 | 0 | $0 |
2015-10 | 0 | $0 | 2,000 | $79,380 | 0 | $0 |
2015-09 | 0 | $0 | 2,000 | $122,380 | 0 | $0 |
2015-08 | 0 | $0 | 17,000 | $1,131,809 | 15,000 | $223,650 |
2015-07 | 0 | $0 | 22,000 | $1,638,820 | 20,000 | $259,800 |
2015-06 | 0 | $0 | 122,359 | $8,484,931 | 66,234 | $877,398 |
2015-01 | 0 | $0 | 1,250,000 | $58,119,179 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-10-01 | Camber Capital Management Lp | Sale | 4,390,000 | 13.57 | 59,585,470 |
2020-03-16 | Boyd Steven | Buy | 24,000 | 4.87 | 116,880 |
2020-02-25 | Boyd Steven | Buy | 36,000 | 8.29 | 298,439 |
2020-01-27 | Boyd Steven | Buy | 16,000 | 6.28 | 100,480 |
2020-01-24 | Boyd Steven | Buy | 74,000 | 6.43 | 476,042 |
2020-01-10 | Boyd Steven | Buy | 18,000 | 5.82 | 104,760 |
2020-01-09 | Boyd Steven | Buy | 12,466 | 6.17 | 76,852 |
2020-01-09 | Boyd Steven | Sale | 12,466 | 6.21 | 77,476 |
2019-08-09 | Camber Capital Management Lp | Buy | 30,000 | 9.06 | 271,770 |
2019-08-07 | Boyd Steven | Buy | 300,000 | 4.92 | 1,475,100 |
2019-08-07 | Camber Capital Management Lp | Buy | 355,000 | 7.70 | 2,733,500 |
2019-06-27 | Boyd Steven | Buy | 64,000 | 6.33 | 405,120 |
2019-06-26 | Boyd Steven | Buy | 120,000 | 4.57 | 547,800 |
2019-06-25 | Boyd Steven | Buy | 314,016 | 6.58 | 2,064,655 |
2019-05-28 | Krop Julie (Chief Medical Officer) | Buy | 10,000 | 9.91 | 99,100 |
2019-05-09 | Bolgiano Elizabeth Scott (Chief Human Resources Officer) | Buy | 5,000 | 10.93 | 54,650 |
2019-05-09 | Heiden William K (President & CEO) | Buy | 10,000 | 10.70 | 107,000 |
2019-03-07 | Vittiglio Joseph (EVP, General Counsel) | Sale | 1,425 | 14.01 | 19,964 |
2018-08-07 | Heiden William K (President & CEO) | Sale | 5,000 | 25.00 | 125,000 |
2018-06-04 | Heiden William K (President & CEO) | Sale | 20,000 | 25.00 | 500,000 |
2018-03-06 | Vittiglio Joseph (EVP, General Counsel) | Sale | 770 | 20.80 | 16,016 |
2017-08-29 | Vittiglio Joseph (SVP, General Counsel) | Sale | 1,250 | 16.75 | 20,937 |
2017-07-13 | Krop Julie (SVP Clinical & Regulatory, CMO) | Sale | 4,938 | 20.00 | 98,760 |
2017-05-01 | Krop Julie (SVP Clinical & Regulatory, CMO) | Sale | 1,891 | 24.45 | 46,234 |
2016-10-20 | Krop Julie (SVP Clinical & Regulatory, CMO) | Sale | 4,938 | 24.80 | 122,462 |
2015-11-10 | Fallon John A. | Buy | 3,230 | 31.20 | 100,776 |
2015-10-01 | Heiden William K (CEO) | Sale | 2,000 | 39.69 | 79,380 |
2015-09-01 | Heiden William K (CEO) | Sale | 2,000 | 61.19 | 122,380 |
2015-08-05 | Thomas Frank E (President & COO) | Sale | 15,000 | 66.85 | 1,002,749 |
2015-08-05 | Thomas Frank E (President & COO) | Option Ex | 15,000 | 14.91 | 223,650 |
2015-08-03 | Heiden William K (CEO) | Sale | 2,000 | 64.53 | 129,060 |
2015-07-15 | Heiden William K (CEO) | Sale | 20,000 | 75.00 | 1,500,000 |
2015-07-15 | Heiden William K (CEO) | Option Ex | 20,000 | 12.99 | 259,800 |
2015-07-01 | Heiden William K (CEO) | Sale | 2,000 | 69.41 | 138,820 |
2015-06-15 | Holmes Scott A (SVP, Finance and Treasurer) | Sale | 7,580 | 66.63 | 505,055 |
2015-06-15 | Holmes Scott A (SVP, Finance and Treasurer) | Option Ex | 6,234 | 15.72 | 97,998 |
2015-06-05 | Heiden William K (CEO) | Sale | 66,875 | 69.80 | 4,668,142 |
2015-06-05 | Heiden William K (CEO) | Option Ex | 60,000 | 12.99 | 779,400 |
2015-06-04 | Thomas Frank E (President & COO) | Sale | 20,000 | 69.52 | 1,390,300 |
2015-06-03 | Wilson Kenneth H (SVP, Sales and Marketing) | Sale | 5,388 | 68.77 | 370,532 |
2015-06-03 | Holmes Scott A (SVP, Finance and Treasurer) | Sale | 22,516 | 68.88 | 1,550,902 |
2015-01-09 | Gross Phillip | Sale | 17,493 | 43.48 | 760,595 |
2015-01-08 | Gross Phillip | Sale | 142,507 | 46.06 | 6,564,584 |
2015-01-07 | Gross Phillip | Sale | 1,090,000 | 46.60 | 50,794,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AVM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amag Pharmaceuticals, Inc. (symbol AVM, CIK number 792977) see the Securities and Exchange Commission (SEC) website.